Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells

Figure 2

HNHA suppressed RCC tumor cell proliferation. Cell viability and cell adhesion assays showed that HNHA induced the greatest inhibition of tumor cell proliferation in Caki-1 (A-C) and A-498 cells (D-F) Points indicate mean % of the solvent-treated control. (A, D) and (B, E) experiments were repeated at least three times with similar results. *P < 0.05 vs. Control, **P < 0.01 vs. Control, ***P < 0.005 vs. Control.

Back to article page